Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D003864:Depression, Chemical; D005246:Feedback; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D008680:Metaraminol / Q000378:metabolism; D009130:Muscle, Smooth / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009411:Nerve Endings / Q000187:drug effects*; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism*; D010477:Perfusion; D011817:Rabbits; D051381:Rats; D011955:Receptors, Drug; D013564:Sympathetic Nervous System / Q000187:drug effects*; D009435:Synaptic Transmission; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D011955:Receptors, Drug; D014316:Tritium; D000804:Angiotensin II; D008680:Metaraminol; D014446:Tyrosine 3-Monooxygenase; D000251:Adenosine Triphosphatases; D009638:Norepinephrine